Purchase Order 36C24226P0478
- Not listed
- Priority Healthcare Distribution Inc., operating through its Curascript SD Specialty Distribution division, has been awarded a firm fixed-price purchase order valued at $15,746.12 by Veterans Integrated Service Network 2, a civilian agency within the Department of Veterans Affairs. The contract, awarded on January 22, 2026, with an ultimate completion date of April 22, 2026, covers the supply of Tyvaso, a specialty pharmaceutical used to treat pulmonary arterial hypertension through inhalation...
- Priority Healthcare Distribution Inc., operating through its Curascript SD Specialty Distribution division, was awarded a firm fixed-price purchase order valued at $15,746.12 by Veterans Integrated Service Network 2 on February 18, 2026. The contract, with an ultimate completion date of May 18, 2026, covers the supply of Tyvaso (treprostinil inhalation solution), a specialty pharmaceutical used in the treatment of pulmonary arterial hypertension. The award was made without set-aside...
- This federal contract award is for the supply of a Tyvaso DPI (Treprostinil Inhalation Powder) titration kit to the Department of Veterans Affairs Veterans Health Administration. The contract was awarded to Priority Healthcare Distribution Inc., a for-profit organization, through its Curascript SD Specialty Distribution division. The contract has a firm fixed price of $16,010.87 and a completion date of June 21, 2024. The contract does not have a set-aside designation. Priority Healthcare...
- This federal contract award is for pharmaceutical products to be provided by Priority Healthcare Distribution Inc. through its Curascript SD Specialty Distribution division. The $131,685.94 firm fixed-price purchase order was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to support VA hospitals and clinics. The contract does not have a set-aside designation. Priority Healthcare Distribution is a for-profit organization that has received numerous federal...
- The U.S. Department of Veterans Affairs (VA) awarded a firm-fixed price purchase order contract to Priority Healthcare Distribution Inc., doing business as Curascript SD Specialty Distribution, to provide pharmaceutical products. The contract has a ceiling value of $76,863.55 and an ultimate completion date of September 24, 2019. The contract is not designated as a set-aside. Priority Healthcare Distribution Inc. is a for-profit organization that specializes in supplying specialized and...
- This federal contract award was issued by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to Priority Healthcare Distribution Inc. for the provision of pharmaceuticals. The contract has a firm fixed price structure and a potential value of $275,132.88. It does not have a set-aside designation. Through its Curascript SD Specialty Distribution division, Priority Healthcare Distribution Inc. provides integrated delivery solutions for...
- This federal contract award to Priority Healthcare Distribution Inc., through its Curascript SD Specialty Distribution division, provides pharmaceutical products and distribution services to support patient care programs at various U.S. government agencies. The $121,572.80 firm fixed price contract was issued by the Department of Veterans Affairs Veterans Health Administration, and does not have a set-aside designation. The contract delivers a range of pharmaceuticals, including cardiovascular...
- This contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to Priority Healthcare Distribution Inc., a for-profit organization. The $159,717.00 firm fixed price contract is for the delivery of pharmaceuticals, with a completion date of October 20, 2018. The contract did not utilize a set-aside designation. Priority Healthcare Distribution Inc., through its Curascript SD Specialty Distribution division, provides integrated...
- Priority Healthcare Distribution Inc. will provide one line item pharmaceutical valued at two hundred thirty-three thousand nine hundred fifty-one dollars and twenty cents ($233,951.20) to the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 7 under a firm fixed-price purchase order awarded on February 8, 2024. As the prime contractor, Priority Healthcare Distribution's Curascript SD Specialty Distribution division will deliver the medication to...
- This federal contract award was issued by the Department of Veterans Affairs (VA) Veterans Health Administration to Priority Healthcare Distribution Inc. through its Curascript SD Specialty Distribution division. The $175,587.60 firm fixed price purchase order is for the supply of a single line item pharmaceutical product. The contract has no set-aside designation and will be performed at Priority Healthcare's facility in Lake Mary, Florida. As a prime contractor, Priority Healthcare...
Priority Healthcare Distribution Inc., operating through its Curascript SD Specialty Distribution division, was awarded a firm fixed-price purchase order valued at $15,746.12 by the Veterans Integrated Service Network 2 on March 16, 2026. The contract, with an ultimate completion date of June 16, 2026, covers the supply of Tyvaso Kit, a specialty pharmaceutical product used in the treatment of pulmonary arterial hypertension. The award carries no set-aside designation and represents a routine pharmaceutical replenishment order to support the VA's healthcare delivery mission. Performance will be executed from the vendor's Lake Mary, Florida location. Priority Healthcare Distribution is an established pharmaceutical distributor with extensive experience supplying specialty medications to federal agencies, particularly the Department of Veterans Affairs and the Bureau of Prisons. The company maintains expertise in distributing high-cost, complex medications for rare and chronic disease states and has held an active System for Award Management registration since October 2002. This contract aligns with the VA's commitment to providing advanced pharmaceutical therapies to veterans requiring treatment for serious pulmonary conditions, leveraging the vendor's established capabilities as a sole-source or preferred distributor for specialty pharmaceutical products within the federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.7k | 3/15/26 |